NCT07463001 Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities
| NCT ID | NCT07463001 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian University of Science and Technology |
| Condition | School Attendance Problems |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2026-04-10 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study we will investigate the effects of an intervention called Back2School, revised and adapted for Norwegian conditions on school attendance. A total of 240 participants will be recruited. All participants who have been enrolled will receive the intervention. Half of the participants will receive the intervention without delay (the experiment group), and the other half will receive it following a 13-week period (the control group). Following consent, screening for eligibility and randomization, the intervention will start with an assessment related to the individual participant and condition at the participants' school. Based on this a shared understanding and an intervention plan is developed. Over a 13-week period the youth, the family and the school, work together guided by the municipal team to increase attendance and solve problems related to this. Assessments will be carried out after the intervention and 6 months later.
Eligibility Criteria
Inclusion Criteria: 1. Participants must be between the ages of 9 and 15 at the time of enrollment. 2. Participants must have less than 80% attendance for the last 12 weeks of school at the time of screening. 3. At least one parent has to talk and understand Norwegian. 4. At least one parent has to be motivated to participate. 5. The school must agree to participate in the intervention Exclusion Criteria: 1 The participant has a known diagnosis of autism-spectrum disorder, psychosis, and/or eating disorder. 2\. Participant needs acute psychiatric intervention.
Contact & Investigator
Jo Magne Ingul, phd
PRINCIPAL INVESTIGATOR
Norwegian University of Science and Technology
Frequently Asked Questions
Who can join the NCT07463001 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 15 Years, studying School Attendance Problems. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07463001 currently recruiting?
Yes, NCT07463001 is actively recruiting participants. Contact the research team at jo.m.ingul@ntnu.no for enrollment information.
Where is the NCT07463001 trial being conducted?
This trial is being conducted at Bergen, Norway, Oslo, Norway, Tromsø, Norway, Trondheim, Norway.
Who is sponsoring the NCT07463001 clinical trial?
NCT07463001 is sponsored by Norwegian University of Science and Technology. The principal investigator is Jo Magne Ingul, phd at Norwegian University of Science and Technology. The trial plans to enroll 240 participants.